XML 21 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
COMMON STOCK
CAPITAL SURPLUS
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
RETAINED EARNINGS
Balance at beginning of period, (in shares) at Dec. 31, 2014   135,134      
Balance at beginning of period at Dec. 31, 2014   $ 135 $ 928,157 $ 14,730 $ 36,836
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net issuances of restricted stock, (in shares)   785      
Net issuances of restricted stock   $ 1 (1)    
Repurchases of common stock, (in shares)   (4,817)      
Repurchases of common stock   $ (5)     (252,916)
Stock-based compensation expense     41,292    
Exercises of stock options, (in shares) 54 54      
Exercises of stock options   $ 0 1,529    
Tax impact of equity incentive plans     8,500    
Foreign currency translation adjustments, net of tax $ (25,024)     (25,024)  
Net income $ 357,796       357,796
Cash dividends         (107,249)
Balance at end of period, (in shares) at Dec. 31, 2015   131,156      
Balance at end of period at Dec. 31, 2015   $ 131 979,477 (10,294) 34,467
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net issuances of restricted stock, (in shares)   1,039      
Net issuances of restricted stock   $ 1 (1)    
Repurchases of common stock, (in shares)   (4,405)      
Repurchases of common stock   $ (4)     (178,780)
Stock-based compensation expense     42,699    
Exercises of stock options, (in shares) 7 7      
Exercises of stock options   $ 0 223    
Tax impact of equity incentive plans     13    
Foreign currency translation adjustments, net of tax $ (10,208)     (10,208)  
Net income 343,389       343,389
Cash dividends         (114,514)
Balance at end of period, (in shares) at Dec. 31, 2016   127,797      
Balance at end of period at Dec. 31, 2016 $ 1,086,599 $ 128 1,022,411 (20,502) 84,562
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net issuances of restricted stock, (in shares)   918      
Net issuances of restricted stock   $ 1 (1)    
Repurchases of common stock, (in shares)   (4,454)      
Repurchases of common stock   $ (5)     (217,031)
Stock-based compensation expense     42,191    
Exercises of stock options, (in shares) 0 0      
Exercises of stock options   $ 0 0    
Tax impact of equity incentive plans     0    
Foreign currency translation adjustments, net of tax $ 24,009     24,009  
Net income 290,584       290,584
Cash dividends         (121,082)
Balance at end of period, (in shares) at Dec. 31, 2017   124,261      
Balance at end of period at Dec. 31, 2017 $ 1,105,265 $ 124 $ 1,064,601 $ 3,507 $ 37,033